{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:13Z","timestamp":1793895973110,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1210303"],"award-info":[{"award-number":["2024YFA1210303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1206001"],"award-info":[{"award-number":["2022YFA1206001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473142"],"award-info":[{"award-number":["52473142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115045","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:09:48Z","timestamp":1779548988000},"page":"115045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Macrophage-hitchhiking nanomedicine codelivering gemcitabine and KRAS G12D inhibitor orchestrates chemo-immunotherapy for metastatic colorectal cancer"],"prefix":"10.1016","volume":"396","author":[{"given":"Luying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runkai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115045_bb0005","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115045_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1200\/JCO.2024.42.3_suppl.105","article-title":"A retrospective analysis of the prognostic impact of KRAS G12D mutation in patients with RAS-mutated metastatic colorectal cancer","volume":"42","author":"Hirose","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41698-025-01166-3","article-title":"KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials","volume":"9","author":"Navarro-Jim\u00e9nez","year":"2025","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","article-title":"KRAS inhibitors: resistance drivers and combinatorial strategies","volume":"11","author":"Isermann","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115045_bb0025","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","article-title":"Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor","volume":"28","author":"Hallin","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115045_bb0030","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/2159-8290.CD-25-0349","article-title":"Response and resistance to RAS inhibition in Cancer","volume":"15","author":"Ebright","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115045_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41392-025-02473-8","article-title":"Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges","volume":"10","author":"Choucair","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115045_bb0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1158\/2159-8290.CD-20-0187","article-title":"EGFR blockade reverts resistance to KRASG12C inhibition in colorectal Cancer","volume":"10","author":"Amodio","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115045_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-022-01629-2","article-title":"Targeting KRAS mutant cancers: from druggable therapy to drug resistance","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115045_bb0050","article-title":"An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restoring cetuximab chemosensitivity","volume":"32","author":"Xiang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115045_bb0055","first-page":"277","article-title":"Engineered a dual-targeting HA-TPP\/a nanoparticle for combination therapy against KRAS-TP53 co-mutation in gastrointestinal cancers","volume":"32","author":"Mei","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ccell.2025.07.012","article-title":"Tumor-resident probiotic clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression","volume":"43","author":"Xie","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115045_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer, J. Hematol. Oncol","volume":"15","author":"Weng","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0070","doi-asserted-by":"crossref","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","article-title":"Celecoxib augments paclitaxel-induced immunogenic cell death in triple-negative breast Cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115045_bb0075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.actbio.2025.12.045","article-title":"Micellar co-delivery of KRAS-mutant inhibitors and TLR7\/8 agonists synergizes targeted therapy and immunotherapy in lung cancer","volume":"212","author":"Miao","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216846","article-title":"Immunogenic cell death inducers:Current advances and future perspectives","volume":"542","author":"Lv","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115045_bb0085","first-page":"358","article-title":"All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy","volume":"28","author":"Song","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0090","article-title":"Polymersomal poly(I:C) self-magnifies antitumor immunity by inducing immunogenic cell death and systemic immune activation","volume":"13","author":"Wang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.actbio.2022.04.016","article-title":"CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy","volume":"145","author":"Guo","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0100","article-title":"Dynamic redox-switchable Nanotransducer enabling spatiotemporal cGAS-STING remodeling and immunogenic cell death induction for Cancer immunotherapy","volume":"35","author":"Wang","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0105","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s41467-025-57542-x","article-title":"Quasi Fe MIL-53 nanozyme inducing ferroptosis and immunogenic cell death for cancer immunotherapy","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115045_bb0110","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/acs.biomac.8b00415","article-title":"Organocatalytic ring-opening copolymerization of Trimethylene carbonate and Dithiolane Trimethylene carbonate: impact of Organocatalysts on copolymerization kinetics and copolymer microstructures","volume":"19","author":"Wei","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115045_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113845","article-title":"Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs","volume":"383","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115045_bb0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12951-024-02859-w","article-title":"Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review","volume":"22","author":"Meng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0125","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ccell.2023.07.002","article-title":"KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells","volume":"41","author":"Mahadevan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115045_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0135","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115045_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102729","article-title":"GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation","volume":"62","author":"Ao","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115045_bb0145","first-page":"490","article-title":"ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics","volume":"36","author":"Hu","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0150","doi-asserted-by":"crossref","first-page":"2213967","DOI":"10.1002\/adfm.202213967","article-title":"Design of calixarene-based ICD inducer for efficient cancer immunotherapy","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115045_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153157","article-title":"LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation","volume":"132","author":"Moore","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115045_bb0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115045_bb0165","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41590-023-01578-y","article-title":"Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division","volume":"24","author":"Rudloff","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115045_bb0175","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1073\/pnas.0915000107","article-title":"Two physically, functionally, and developmentally distinct peritoneal macrophage subsets","volume":"107","author":"Ghosn","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115045_bb0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fimmu.2015.00225","article-title":"Revisiting mouse peritoneal macrophages: heterogeneity, development, and function","volume":"6","author":"Cassado","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115045_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215667","article-title":"CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis","volume":"537","author":"Shang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115045_bb0190","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1021\/acs.nanolett.8b00689","article-title":"Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating MicroRNA-125b","volume":"18","author":"Parayath","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115045_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114155","article-title":"Macrophage hitchhiking for smart nanomedicine: bridging immune navigation and targeted therapy","volume":"386","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115045_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102068","article-title":"Macrophage-hitchhiking interleukin-10 plasmid DNA delivery system modulates rheumatoid arthritis microenvironment via the re-polarization of macrophages","volume":"54","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115045_bb0205","doi-asserted-by":"crossref","first-page":"eadw7191","DOI":"10.1126\/sciadv.adw7191","article-title":"Macrophage hitchhiking nanomedicine for enhanced \u03b2-elemene delivery and tumor therapy","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115045_bb0210","doi-asserted-by":"crossref","first-page":"33075","DOI":"10.1021\/jacs.4c10562","article-title":"A multifunctional peptide nucleic acid\/peptide copolymer-based dual-mode biosensor with macrophage-hitchhiking for enhanced tumor imaging and urinalysis","volume":"146","author":"Wei","year":"2024","journal-title":"J. Am. Chem. Soc."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:47:48Z","timestamp":1793893668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S0168365926004487"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115045","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage-hitchhiking nanomedicine codelivering gemcitabine and KRAS G12D inhibitor orchestrates chemo-immunotherapy for metastatic colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115045"}}